91原创

Healthcare News & Views

Bluewater Health Partners with 91原创 for Enhanced Total Joint Replacement Surgical Outcomes

August 26, 2021
By
seamless

Bluewater Health recently published highlighting the launch of 91原创 to virtually guide patients undergoing Total Joint Replacement Surgery through pre-surgical preparation through post-surgical recovery. Ontario surgical patients residing in the Sarnia-Lambton area now benefit from 鈥檚 user-friendly Digital Patient Engagement platform that offers personalized education, automated reminders, progress-tracking, and post-op symptom monitoring on any device (e.g. smartphone, tablet, computer).

Here is an excerpt from the article:

鈥淚t is our goal to pilot the platform with our orthopaedic surgery team and their patients, with high potential to spread to other departments and specialties,鈥 says Dr. Alvaro Ramirez, Medical Director/Chief of Surgery and Ambulatory Care. 鈥淎ll patients requiring complex surgeries or procedures could really benefit from this tool. We want our patients to feel as prepared as possible before and after their surgery; and the 91原创漏 platform offers that next level of interactive support and assurance for our patients and their caregivers.鈥

We are excited to continue to support 鈥檚 dedication to the delivery of innovative patient care solutions for improved clinical outcomes such as reduced ED visits, hospital length of stay, and readmissions.


Bluewater Health Partners with 91原创 for Enhanced Total Joint Replacement Surgical Outcomes

Posted by:
seamless
on
August 26, 2021

Bluewater Health recently published highlighting the launch of 91原创 to virtually guide patients undergoing Total Joint Replacement Surgery through pre-surgical preparation through post-surgical recovery. Ontario surgical patients residing in the Sarnia-Lambton area now benefit from 鈥檚 user-friendly Digital Patient Engagement platform that offers personalized education, automated reminders, progress-tracking, and post-op symptom monitoring on any device (e.g. smartphone, tablet, computer).

Here is an excerpt from the article:

鈥淚t is our goal to pilot the platform with our orthopaedic surgery team and their patients, with high potential to spread to other departments and specialties,鈥 says Dr. Alvaro Ramirez, Medical Director/Chief of Surgery and Ambulatory Care. 鈥淎ll patients requiring complex surgeries or procedures could really benefit from this tool. We want our patients to feel as prepared as possible before and after their surgery; and the 91原创漏 platform offers that next level of interactive support and assurance for our patients and their caregivers.鈥

We are excited to continue to support 鈥檚 dedication to the delivery of innovative patient care solutions for improved clinical outcomes such as reduced ED visits, hospital length of stay, and readmissions.


Recent news from 91原创

235: Beacon's CIDEO Dr. Stacey Johnston: Pushing Oracle to Its AI Limits, The Agent That Ordered 7,000 Colon Screenings and Caught Cancer Early, and What If You Spent More on Tech Than on Recruiting?
August 20, 2026

235: Beacon's CIDEO Dr. Stacey Johnston: Pushing Oracle to Its AI Limits, The Agent That Ordered 7,000 Colon Screenings and Caught Cancer Early, and What If You Spent More on Tech Than on Recruiting?

Learn More
234: Parkview's ACMIO Dr. Hasan Ahmad: Why Deleting EHR Alerts Is the Safest Thing You'll Do This Year, Three Questions Every AI Tool Must Answer Before Go-Live, and Why Resistance Is Usability Feedback
August 13, 2026

234: Parkview's ACMIO Dr. Hasan Ahmad: Why Deleting EHR Alerts Is the Safest Thing You'll Do This Year, Three Questions Every AI Tool Must Answer Before Go-Live, and Why Resistance Is Usability Feedback

Learn More
233: Northwestern's CMO, Pop Health Dr. Amish Desai: Making 2,500 AI Calls in 5 Days that Patients Loved,聽 The Scale-First Rule That Kills Pilotitus, and Why You Should Judge AI by the Alternative
July 23, 2026

233: Northwestern's CMO, Pop Health Dr. Amish Desai: Making 2,500 AI Calls in 5 Days that Patients Loved,聽 The Scale-First Rule That Kills Pilotitus, and Why You Should Judge AI by the Alternative

Learn More